Tag: Continuous Glucose Monitor (CGM)
Eastern MedTech adds contracting executive
December 17, 2024HME News Staff
BOSTON – Eastern MedTech, a provider of continuous glucose monitoring and maternity supplies, has appointed Heather Davis as vice president of national value-based care contracting. “Eastern MedTech believes that value-based care is essential to addressing the health care cost crisis,” said Peter Falkson, CEO/founder at Eastern MedTech. “By aligning incentives between providers and health plans, value-based care models encourage collaboration and innovation to deliver high-quality,...
Stakeholders push two-channel option for CGMs
November 27, 2024Theresa Flaherty, Managing Editor
WASHINGTON – Users of continuous glucose monitors have reported difficulties obtaining equipment and supplies when their insurers eliminate coverage under DME, adding more evidence that there needs to be a two-channel option, stakeholders say.
As CMS has expanded coverage of CGMs and supplies, some payers have begun making it a pharmacy-only benefit, limiting brand choices and narrowing networks.
“One patient wrote that they attempted to obtain sensors from three different...
In brief: Henry Schein makes CGM play, diabetes tech integrates, Medicare overpays & more
November 22, 2024HME News Staff
MELVILLE, N.Y. - Henry Schein has signed an agreement to buy Tampa, Fla.-based Acentus, a national supplier specializing in delivering continuous glucose monitors (CGMs) with $35 million in annual revenue.
Along with its previous acquisitions of Prism Medical Products in 2021 and Shield Healthcare and Mini Pharmacy in 2023, Henry Schein now expects its home medical supply platform to have annual revenue of about $350 million.
“As the delivery of health care in the U.S. is...
Insulet’s Omnipod integrates with Libre
November 21, 2024HME News Staff
ACTON, Mass. – Insulet’s Omnipod 5 Automated Insulin Delivery System is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous glucose monitoring sensor in the U.S. “We are excited to announce that Omnipod 5, the only AID system indicated for both Type 1 and Type 2 diabetes, is now integrated with Abbott’s FreeStyle Libre 2 Plus sensor in the U.S.,” aid Eric Benjamin, Insulet’s executive vice president and chief product and customer experience officer....
Henry Schein expands supplies platform with Acentus
November 20, 2024HME News Staff
MELVILLE, N.Y. - Henry Schein has signed an agreement to buy Tampa, Fla.-based Acentus, a national supplier specializing in delivering continuous glucose monitors (CGMs) with $35 million in annual revenue.
Along with its previous acquisitions of Prism Medical Products in 2021 and Shield Healthcare and Mini Pharmacy in 2023, Henry Schein now expects its home medical supply platform to have annual revenue of about $350 million.
“As the delivery of health care in the U.S. is...
Abbott opens new facility for sensors, CGMs
November 18, 2024HME News Staff
ABBOTT PARK, Ill. – Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, Ireland, part of its €440 million investment in the country. The new 30,000-square-meter Kilkenny facility is producing FreeStyle Libre 3 sensors and the latest generation in Abbott’s continuous glucose monitoring portfolio for people living with diabetes. "This is our latest commitment to providing innovative care and supporting...
FDA says OK to leave FreeStyle Libre CGMs on for imaging
October 30, 2024HME News Staff
ABBOTT PARK, Ill. – Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT scans and MRIs. The U.S. Food and Drug Administration has cleared the removal of the imaging contraindication, making Abbott’s systems the first and only patient-applied CGM sensors approved for these screenings. "For people with diabetes, especially those using insulin, removing a CGM...
In brief: Hurricane waivers, NIV advocacy, CRT lobby
October 4, 2024HME News Staff
WASHINGTON – CMS will permit people with Medicare who have lost or had damage to their DMEPOS products because of Hurricane Helene to receive replacements of such items and services, according to a bulletin from AAHomecare.
Specifically, CMS waivers for Florida, Georgia, North Carolina, South Carolina, and Tennessee state that:
When DMEPOS is lost, destroyed, irreparably damaged, or otherwise rendered unusable, CMS is allowing DME MACs to have the flexibility to waive...
AAH strengthens NIV, CGM advocacy
October 3, 2024HME News Staff
WASHINGTON – AAHomecare has expanded its relationship with legal and public policy firm Foley Hoag to strengthen its advocacy work on significant coverage issues for non-invasive ventilators and continuous glucose monitors. “Foley Hoag’s expertise in Medicare and Medicaid policy is already helping us sharpen our arguments by identifying established laws and regulations that support our advocacy goals,” said Tom Ryan, president and CEO of AAHomecare. “In addition, their...
Ascensia launches Eversense 365
October 3, 2024HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care has launched its Eversense 365 continuous glucose monitoring system, which received clearance from the U.S. Food and Drug Administration in September. “Eversense offers a completely differentiated CGM experience, overcoming many of the frustrations experienced with traditional, short-term CGMs, such as early failure, disruptive false alerts and skin irritation,” said Brian Hansen, president of CGM at Ascensia. “With only one CGM replacement...